Literature DB >> 26837962

miR-17-92 host gene, uderexpressed in gastric cancer and its expression was negatively correlated with the metastasis.

F Bahari, M Emadi-Baygi, P Nikpour1.   

Abstract

BACKGROUND: This study aimed to evaluate the expression of miR-17-92 host gene (MIR17HG), in gastric cancer and paired normal adjacent tissues for the 1st time.
METHODS: Using quantitative real-time-polymerase chain reaction, the MIR17HG expression was assessed in 30 paired tumoral and nontumoral gastric tissue samples.
RESULTS: Our results showed that this transcript was significantly underexpressed in gastric tumors compared with normal ones. Furthermore, there was an association between the expression levels of MIR17HG and gastric cancer grades and stages. Moreover, the expression level of MIR17HG was conversely associated with the size of tumoral specimens in early stages (stages I and II). We also observed an association between the presence of metastasis and lower expression of MIR17HG.
CONCLUSION: Our results suggest that MIR17HG gene expression is dysregulated in gastric cancer in which it may indicate a tumor suppressive function of this miRNA cluster host gene in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26837962     DOI: 10.4103/0019-509X.175605

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  12 in total

1.  The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma.

Authors:  Xiulei Zhang; Peiming Zheng; Zhen Li; Shanjun Gao; Guangzhi Liu
Journal:  Onco Targets Ther       Date:  2020-08-04       Impact factor: 4.147

2.  Dual Attention Mechanisms and Feature Fusion Networks Based Method for Predicting LncRNA-Disease Associations.

Authors:  Yu Liu; Yingying Yu; Shimin Zhao
Journal:  Interdiscip Sci       Date:  2022-01-24       Impact factor: 2.233

3.  miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer.

Authors:  Fangliang Yang; Yuan Li; Lingyun Xu; Yulan Zhu; Haiyan Gao; Lin Zhen; Lin Fang
Journal:  Onco Targets Ther       Date:  2017-01-27       Impact factor: 4.147

4.  Graph Convolutional Network and Convolutional Neural Network Based Method for Predicting lncRNA-Disease Associations.

Authors:  Ping Xuan; Shuxiang Pan; Tiangang Zhang; Yong Liu; Hao Sun
Journal:  Cells       Date:  2019-08-30       Impact factor: 6.600

5.  MicroRNA-9 inhibits gastric cancer cell proliferation and migration by targeting neuropilin-1.

Authors:  Cheng Hang; Hui-Shen Yan; Chen Gong; Hua Gao; Qiu-Hui Mao; Jian-Xin Zhu
Journal:  Exp Ther Med       Date:  2019-08-02       Impact factor: 2.447

6.  Upregulated microRNA-106a Promotes Porcine Preadipocyte Proliferation and Differentiation by Targeting Different Genes.

Authors:  Kuilong Huang; Xin'e Shi; Jie Wang; Ying Yao; Ying Peng; Xiaochang Chen; Xiao Li; Gongshe Yang
Journal:  Genes (Basel)       Date:  2019-10-14       Impact factor: 4.096

7.  MiR-17-5p and miR-20a promote chicken cell proliferation at least in part by upregulation of c-Myc via MAP3K2 targeting.

Authors:  Xiaofei Zhang; He Song; Shupei Qiao; Jing Liu; Tianyu Xing; Xiaohong Yan; Hui Li; Ning Wang
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

8.  Selecting lncRNAs in gastric cancer cells for directed therapy with bioactive peptides and chemotherapy drugs.

Authors:  Wenyan Han; Rui Xiao; Chuanling Zhang; Qimuge Suyila; Xian Li; Xiulan Su
Journal:  Oncotarget       Date:  2017-09-18

9.  MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.

Authors:  ShiJuan Mai; RuoWen Xiao; Lu Shi; XiaoMin Zhou; Te Yang; MeiYin Zhang; NuoQing Weng; XinGe Zhao; RuiQi Wang; Ji Liu; Rui Sun; HaiDe Qin; HuiYun Wang
Journal:  Cell Death Dis       Date:  2019-10-28       Impact factor: 8.469

Review 10.  Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Soheil Hassanipour; Hamid Salehiniya
Journal:  Clin Exp Gastroenterol       Date:  2020-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.